TrialPloS one2015

Lipocalin (LCN) 2 Mediates Pro-Atherosclerotic Processes and Is Elevated in Patients with Coronary Artery Disease.

Raghav Oberoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.